We have been watching the Darvocet multi-district litigation (MDL 2226) for some time, most notably the Sixth Circuit’s decision to dismiss 67 of 68 cases alleging misbranding by drug manufacturers. After that decision, plaintiffs’ counsel began filing new cases in California state court. The defendants removed the cases to federal court and then obtained a … Continue Reading
The Sixth Circuit has recently decided a landmark case regarding the constitutionality of health care reform. Now, it is being asked again to review a case of great significance to the provision of health care services. In United States of America v. Blue Cross/Blue Shield of Michigan, (Eastern District of Michigan), the federal and state … Continue Reading
